Title : Complete and Sustained Off-Therapy Response to Sorafenib in Advanced Hepatocellular Carcinoma.

Pub. Date : 2016 Jun

PMID : 27308660






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Therapy with sorafenib 400 mg bid was started and the subsequent dynamic CT performed at the 10th month of therapy showed a complete response according to RECIST criteria and mRECIST, while seriated dosages of alpha-fetoprotein levels showed a progressive reduction up to normalization. Sorafenib alpha fetoprotein Homo sapiens